Cargando…

Prediction of response to tapentadol in chronic low back pain

BACKGROUND: Many chronic low back pain (cLBP) patients do not satisfactorily respond to treatment. The knowledge of responders and non‐responders before initiating treatment would improve decision making and reduce health care costs. The aims of this exploratory prediction study in cLBP patients tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reimer, M., Hüllemann, P., Hukauf, M., Keller, T., Binder, A., Gierthmühlen, J., Baron, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248647/ https://www.ncbi.nlm.nih.gov/pubmed/27510567 http://dx.doi.org/10.1002/ejp.926

Ejemplares similares

A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
por: Otto, Jan C., et al.
Publicado: (2019)

Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?
por: Pergolizzi, Joseph, et al.
Publicado: (2011)

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2018)

Tapentadol: an effective option for the treatment of back pain
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

Tapentadol: an effective option for the treatment of back pain [Corrigendum]
Publicado: (2019)

Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitization
por: van de Donk, Tine, et al.
Publicado: (2020)

Tapentadol versus tramadol in the management of low back pain in the emergency department: Impact of use on the need for reassessments
por: Guillén-Astete, Carlos A., et al.
Publicado: (2017)

Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017)

Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)

The early influence of COVID-19 pandemic-associated restrictions on pain, mood, and everyday life of patients with painful polyneuropathy
por: Kersebaum, Dilara, et al.
Publicado: (2020)

Sensory bedside testing: a simple stratification approach for sensory phenotyping
por: Reimer, Maren, et al.
Publicado: (2020)

Test–retest reliability of a simple bedside-quantitative sensory testing battery for chronic neuropathic pain
por: Sachau, Juliane, et al.
Publicado: (2023)

Sensitization of the Nociceptive System in Complex Regional Pain Syndrome
por: Reimer, Maren, et al.
Publicado: (2016)

Neuropathic low back pain in clinical practice
por: Baron, R., et al.
Publicado: (2016)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain
por: Samolsky Dekel, Boaz G., et al.
Publicado: (2015)

Bridging the Gap Between Vessels and Nerves in Fabry Disease
por: Forstenpointner, Julia, et al.
Publicado: (2020)

Pain reduction induced by tapentadol in patients with musculoskeletal chronic pain fosters better sleep quality
por: Vellucci, Renato, et al.
Publicado: (2021)

Stratification of patients with unclassified pain in the FabryScan database
por: Forstenpointner, Julia, et al.
Publicado: (2019)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

Tapentadol for neuropathic pain: a review of clinical studies
por: Freo, Ulderico, et al.
Publicado: (2019)

Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015)

The pandemic’s effect on a patient cohort with painful polyneuropathy in 2020: A longitudinal study on pain, mood, and everyday life
por: Kersebaum, Dilara, et al.
Publicado: (2022)

The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms
por: Passavanti, Maria Beatrice, et al.
Publicado: (2017)

Correction to: Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2019)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Tapentadol: a new option for the treatment of cancer and noncancer pains
por: Dickenson, Anthony H, et al.
Publicado: (2019)

Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
por: Howard, Richard F, et al.
Publicado: (2020)

Sensitized vasoactive C-nociceptors: key fibers in peripheral neuropathic pain
por: Forstenpointner, Julia, et al.
Publicado: (2019)

Driving Ability in Patients with Severe Chronic Low Back or Osteoarthritis Knee Pain on Stable Treatment with Tapentadol Prolonged Release: A Multicenter, Open-label, Phase 3b Trial
por: Sabatowski, Rainer, et al.
Publicado: (2014)

Tapentadol: an overview of the safety profile
por: Polati, Enrico, et al.
Publicado: (2019)

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study
por: Steigerwald, Ilona, et al.
Publicado: (2012)

The association of self-reported symptoms of central sensitization and sleep disturbances in neuropathic pain
por: Sachau, Juliane, et al.
Publicado: (2023)

Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson’s disease
por: Freo, Ulderico, et al.
Publicado: (2018)

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain
por: Kress, H.G., et al.
Publicado: (2016)

Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats
por: Domínguez-Oliva, Adriana, et al.
Publicado: (2021)

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Tapentadol hydrochloride: A novel analgesic
por: Singh, Dewan Roshan, et al.
Publicado: (2013)

Outcomes of the Pediatric Development Plan of Tapentadol
por: Eerdekens, Mariëlle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ubhtg9ms361kv2nst148jpt4u